COMMUNIQUÉS West-GlobeNewswire

CorVel Announces Quarterly Earnings Release Webcast
19/01/2018
IRVINE, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- In conjunction with CorVel Corporation’s (NASDAQ: CRVL ) quarterly earnings release, CorVel will stream a webcast over the Internet on Tuesday, January 30 th at 11:30 am [...]
Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee
19/01/2018
Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi Appoints Dominique Carouge Executive Vice President Head of Business Transformation and Member of the Executive Committee Paris, France - January 19, 2018 [...]
Sanofi nomme Dominique Carouge au poste de Vice-Président Exécutif, Business Transformation, et membre du Comité Exécutif
19/01/2018
Communiqué de presse Source : Sanofi (EURONEXT: SAN) (NYSE: SNY) Sanofi nomme Dominique Carouge au poste de Vice-Président Exécutif, Business Transformation, et membre du Comité Exécutif Paris, France - Le 19 janvier [...]
Tyme Announces Positive Efficacy Data for SM-88 in Pancreatic Cancer at 2018 ASCO Gastrointestinal Cancers Symposium
19/01/2018
40 percent of evaluable patients achieved survival of more than 12 months, 30 percent achieved a complete or partial tumor response All patients improved or maintained quality of life measures and pain scores SAN [...]
ActivX Biosciences’ KiNativ® platform featured in two articles demonstrating the importance of native kinase profiling for characterizing protein degraders
19/01/2018
LA JOLLA, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- ActivX Biosciences, Inc., a wholly-owned subsidiary of Kyorin Pharmaceutical Co., Ltd. (Tokyo), announces two reports published in high profile, peer-reviewed journals [...]
TRACON Pharmaceuticals Announces Positive Data from Ongoing Phase 1b/2 Trial of TRC105 in Hepatocellular Carcinoma Patients
19/01/2018
Two Partial Responses (25%) by RECIST and Three > 50% Reductions of Alpha Fetoprotein in Eight Evaluable Patients (38%) Treated to Date with Combination of TRC105 and Nexavar® Data Presented at ASCO 2018 [...]
Tauriga Sciences Inc. Completes its Purchase of Crypto Currency Groestlcoin
19/01/2018
NEW YORK, NY, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Tauriga Sciences, Inc. (OTC PINK: TAUG) ("Tauriga" or the "Company"), engaged in building its business through the development, distribution, and licensing of proprietary [...]
PHM Announces Further Details of Plan of Arrangement
19/01/2018
NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN. CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Patient Home [...]
MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
19/01/2018
SOUTH SAN FRANCISCO, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK ), a clinical-stage biopharmaceutical company pioneering a precision medicine approach for the treatment of heritable [...]
XBiotech Announces Presentation of Phase 2 Open Label Extension Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa
19/01/2018
AUSTIN, Texas, Jan. 19, 2018 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ: XBIT ) announced today that results from an open label extension (OLE) phase of the randomized Phase 2 study evaluating XBiotech’s True Human™ [...]
Albireo to Receive More than $55 Million(1) in Nondilutive Cash Payments
19/01/2018
— Elobixibat approved in Japan for the treatment of chronic constipation — — Albireo innovation leads to world’s first approved ileal bile acid transporter (IBAT) inhibitor — BOSTON, Jan. 19, 2018 (GLOBE NEWSWIRE) -- [...]
Avinger Granted Continued Listing Decision From Nasdaq
19/01/2018
REDWOOD CITY, Calif., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR ), a leading developer of innovative treatments for peripheral artery disease (PAD), announced today that the Company has received [...]
VitalHub Corp. Announces the Acquisition of Clarity Healthcare Solutions
19/01/2018
TORONTO, Jan. 19, 2018 (GLOBE NEWSWIRE) -- VITALHUB CORP. (TSXV:VHI) (the “Company” or “VitalHub”), is pleased to announce that it has acquired Clarity Healthcare Solutions and other selected assets of Clarity Health [...]
Kraig Biocraft Laboratories Creates First Hybrids in New Research Center
19/01/2018
ANN ARBOR, Mich., Jan. 19, 2018 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of spider silk based fibers, today announced that the Company succeeded in creating a [...]
Saniona AB: Bulletin from the extraordinary shareholders' meeting on January 19, 2018 in Saniona AB
19/01/2018
PRESS RELEASE January 19, 2018 Today, on January 19, 2018, an extraordinary shareholders' meeting was held in Saniona AB (publ). A summary of the resolutions adopted follows below. All resolutions were adopted with the [...]
Shire plc : Directorate change
19/01/2018
Directorate Change Dublin, Ireland - January 19, 2018 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company") announces that Thomas Dittrich will assume his role as Chief Financial Officer, and become an Executive member [...]
Zealand Pharma strengthens its Management by appointing Ivan Møller as SVP, Technical Development & Operations
19/01/2018
Company announcement - No. 3/2018 Zealand Pharma strengthens its Management by appointing Ivan Møller as SVP, Technical Development & Operations Copenhagen, Denmark, January 19, 2018 - Zealand Pharma A/S ("Zealand [...]
Arimoclomol for NPC receives Rare Pediatric Disease Designation
19/01/2018
Company announcement Orphazyme A/S No. 01/2018 Copenhagen, Denmark, January 19, 2018 – Orphazyme A/S, a Danish biotech company listed on Nasdaq Copenhagen (TICKER: ORPHA.CO), with a late-stage, orphan-drug pipeline, [...]
Motif Bio Announces Filing of U.S. Shelf Registration
19/01/2018
NEW YORK, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Motif Bio® plc (AIM/NASDAQ:MTFB), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has filed a “ [...]

Pages